Niederer Kraft Frey (NKF) advised Sienna Private Equity – mid-market European private equity fund – on its investment in TEC Group. The company Founded by Arnaud Faivre in 2008, TEC Group is a supplier to the Swiss luxury watchmaking industry. The company’s solutions portfolio includes component manufacturing, precision turning, design and production of movements, decoration, […]
Niederer Kraft Frey advised EssilorLuxottica on its recent acquisition of Ikerian, the parent company RetinAI. The parties Headquartered in Bern, Ikerian is a health technology company, operating under the RetinAI brand, active in eyecare through
EuroEyes Group – a globally active clinic group for refractive surgery with headquarters in Hamburg (Germany) – completed the acquisition of several clinics and a surgery theatre across Switzerland and the UK from Swiss laser surgery and
Niederer Kraft Frey (NKF) advised Ecorobotix, a globally active specialist in AI-powered Ultra-High Precision spraying, throughout its Series C and Series D financing rounds, respectively amounting USD 45 million in 2024 and USD 105 million in 2025. In connection
Pestalozzi advised Swiss integrated energy company MET Group throughout its acquisition of the remaining stake in MET Slovakia. Pursuant to the deal, MET Group finalises the buyout process and unlocks full integration of the Slovakian
MLL Legal advised Deutsche Telekom on its acquisition of clinic IT specialist Synedra Schweiz. Headquartered in Innsbruck, Austria, Synedra holds subsidiaries in Germany and Switzerland, serving healthcare structures with solutions for data management. The MLL
Multi-national lottery operator Allwyn underwent a business combination with Greek gaming firm Opap, as a result of an all-share transaction setting the newly created entity at an equity value of EUR 16 billion. In connection with
MLL Legal advised the founders and shareholders of Distona, a Swiss distributor of speciality and basic raw materials, on the company’s sale to the Belgium-based distributor of food ingredients and specialty chemicals Azelis Group.
Unigestion completed the sale of the entire share capital of Unigestion Private Equity Holding – the head holding of Unigestion’s private equity business – to the Canadian alternative asset management group Sagard. In connection with the
Walder Wyss advised ExcellGene and Magellan Biologics & Consulting Global, on the sale of a majority stake to private equity healthcare specialist Archimed. The deal sets to create a group covering gene transfer, cell line
